How should I evaluate and manage a patient with warm bilateral pitting edema, normal estimated glomerular filtration rate, normal liver function tests, progressive normocytic anemia, and proteinuria?

Suspect Glomerular Disease and Pursue Kidney Biopsy

This presentation strongly suggests nephrotic syndrome from glomerular disease, and you should urgently refer to nephrology for kidney biopsy to establish the diagnosis and guide treatment 1, 2.

Diagnostic Approach

Confirm Nephrotic Syndrome

The combination of warm bilateral pitting edema, proteinuria, and progressive normocytic anemia with normal eGFR and LFTs points toward nephrotic syndrome. You need to:

• Quantify proteinuria immediately: Obtain urine protein-to-creatinine ratio (PCR). PCR >300-350 mg/mmol (or >3.5 g/24 hours) confirms nephrotic-range proteinuria 2, 3
• Check serum albumin: Hypoalbuminemia (<30 g/L) is the third component of the nephrotic triad 3
• Examine urine sediment: Look for erythrocyte morphology, red cell casts, and acanthocytes to assess for glomerular hematuria 2

Evaluate for Secondary Causes

Before assuming primary glomerular disease, exclude systemic causes:

• Diabetes screening: HbA1c (though normal eGFR makes diabetic nephropathy less likely as the sole cause)
• Autoimmune workup: ANA, anti-dsDNA, complement levels (C3, C4) for lupus nephritis
• Infection screening: HIV, hepatitis B and C serology
• Malignancy markers: Serum and urine protein electrophoresis with immunofixation to exclude amyloidosis or myeloma
• Specific antibodies: Anti-PLA2R for membranous nephropathy (most common in white adults) 3

Understand the Anemia

The progressive normocytic anemia requires explanation:

• Check reticulocyte count, haptoglobin, LDH, and indirect bilirubin to assess for hemolysis
• Consider bone marrow suppression from chronic inflammation (anemia of inflammation) 4
• Evaluate for occult blood loss if hemolysis markers are negative
• The anemia may be multifactorial in nephrotic syndrome

Management Strategy

Immediate Actions (Before Biopsy)

Edema management 2:

• Loop diuretics as first-line: Start furosemide 40-80 mg twice daily (twice daily dosing is superior to once daily)
• Escalate dose until clinically significant diuresis or maximum effective dose reached
• Consider switching to bumetanide or torsemide if poor response (better bioavailability in nephrotic syndrome)
• Dietary sodium restriction to <2.0 g/day (<90 mmol/day) is essential and synergistic with diuretics

Blood pressure control 2:

• Target systolic BP <120 mmHg using standardized office measurement
• However, do NOT start ACE inhibitors or ARBs yet if you suspect minimal change disease (MCD), as these can cause acute kidney injury in patients presenting with abrupt-onset nephrotic syndrome 2
• Use other antihypertensives (calcium channel blockers, beta-blockers) initially

Thromboprophylaxis consideration:

• Assess thromboembolism risk (serum albumin <20-25 g/L is high risk)
• Consider prophylactic anticoagulation if albumin is severely low, especially with additional risk factors

Urgent Nephrology Referral

Refer within 2 weeks for kidney biopsy 1, 3. The biopsy is essential because:

• Normal eGFR does not exclude significant glomerular disease
• Different histologic diagnoses require vastly different treatments
• In white adults, membranous nephropathy is most common; in those of African ancestry, focal segmental glomerulosclerosis predominates 3
• MCD can present in adults and requires corticosteroid therapy 5

Post-Biopsy Treatment Framework

Once histologic diagnosis is established:

For proteinuria reduction 2:

• Uptitrate ACE inhibitor or ARB to maximally tolerated dose (unless MCD requiring immediate immunosuppression)
• Accept up to 30% increase in serum creatinine if stable
• Monitor potassium closely; use potassium-wasting diuretics or binders to maintain normal potassium and continue RAS blockade
• Target proteinuria <1 g/day (though goals are disease-specific)

For resistant edema 2:

• Add thiazide-like diuretic (any high-dose thiazide is equally effective) for synergistic effect with loop diuretic
• Consider amiloride (reduces potassium loss and improves diuresis)
• Mineralocorticoid receptor antagonists for refractory cases (monitor potassium)
• Ultrafiltration or hemodialysis only if medical management fails

Critical Pitfalls to Avoid

• Do not delay biopsy waiting for conservative management to work—the histologic diagnosis drives specific therapy
• Do not start ACE inhibitors/ARBs empirically in suspected MCD with abrupt-onset nephrotic syndrome (risk of AKI) 2
• Do not ignore the anemia—it may indicate hemolysis, bone marrow involvement, or occult malignancy requiring separate workup
• Do not underestimate thromboembolism risk—nephrotic syndrome carries 15 per 1000 person-years risk of VTE, higher with edema 6
• Counsel patients to hold ACE inhibitors/ARBs and diuretics during volume depletion (sick days, diarrhea, vomiting) 2

The warm edema (suggesting adequate perfusion rather than heart failure) combined with proteinuria and normal liver/kidney function makes glomerular disease the leading diagnosis. The progressive anemia adds urgency—this could represent hemolysis from microangiopathic process, bone marrow involvement from systemic disease, or chronic inflammation. Kidney biopsy is the definitive diagnostic test and should not be delayed 1.